Résumé
Introduction
Contemporary literature has revealed that SARS-CoV-2 causes acute sialadenitis and related symptoms, such as discomfort, pain, swelling, and secretory dysfunction in salivary glands. The secretory dysfunction is due to SARS-CoV-2 infection-induced xerostomia and other associated clinical courses such as sore tongue, mucosal ulcer, and gingivitis in the oral cavity. Furthermore, it has been reported that COVID-19 causes the development of other oral manifestations.
Purpose
This cohort study was initiated to identify the possible oral clinical manifestations of patients with SARS-CoV-2 infection admitted at Eka General Hospital COVID-19 treatment center in Addis Ababa, Ethiopia.
Materials and Methods
A prospective clinical follow-up (a prevalent cohort) study was conducted to identify the possible oral manifestations of SARS-CoV-2 infection among patients admitted at the Eka General Hospital COVID-19 treatment center. Patients were followed for an average period of 3.5 weeks.
Results
The findings of this cohort prevalent study were adjusted around the main objectives of the research. A total of 55 patients (36 males and 19 females) fulfilling the inclusion criteria were included in the cohort. The age of the cohorts ranged from 8 to 90 years. The overall prevalence of oral clinical courses in patients with SARS-CoV-2 was 0.18 (n=10). Oral mucosal lesions, xerostomia, thickening of saliva yielded prevalence data of 0.5 (n=6), 0.42 (n=5), and 0.08 (n=1), respectively. The oral mucosal lesions prevalence finding was further refined into aphthous lesions 0.5 (n=3), candidiasis 0.17 (n=1), geographic tongue 0.17 (n=1), and localized gingivitis 0.17 (n=1).
Conclusion
The findings of the study suggest the importance of initiating oral health care for patients with COVID-19. Therefore, multidisciplinary healthcare approaches to management should be promoted to assure optimal health outcomes. Accordingly, oral health care should be a substantial part of the multidisciplinary approach.
Références
Alharbi, A., Alharbi, S., & Alqaidi, S. (2020). Guidelines for dental care provision during the COVID-19 pandemic. Saudi Dental Journal, 32 (4), 181-186. https://doi.org/10.1016/j.sdentj.2020.04.001.
Aragoneses, J., Suárez, A., Algar, J., Rodríguez, C., & López-Valverde, N. (2020). Oral Manifestations of COVID-19: Updated Systematic Review with Meta-Analysis. Frontiers in Medicine, 8 (726753).
Arino, J., Brauer, F., Driessche, P., V., Watmough, J., & Wu, J. (2006). A simple model for containment of a pandemic. J. R. Soc. Interface, 3, 453-457.
Ather, A., Biraj P., Ruparel, N., B., Diogenes, A., & Hargreaves, M., K. (2020). Coronavirus Disease 19 (COVID-19): Implications for Clinical Dental Care. JOE, 8, 1-6.
Bezerra, T., M., Feitosa, S., G., Carneiro, D., T., O., Costa, F., W., G., Pires, F., R., & Pereira, K., M., A. (2020). Oral lesions in COVID-19 infection: Is long-term follow-up important in the affected patients? Oral Diseases, 00, 1–2. https://doi.org/10.1111/odi.13705.
Biadsee, A, Kassem, F, Dagan, O, Masarwa, M., & Ormianer, Z. (2020). Olfactory and Oral Manifestations of COVID-19: Sex-Related Symptoms-A Potential Pathway to Early Diagnosis. Otolaryngology–Head and Neck Surgery, 1-7.
Capaccio, P., Pignataro, P., Corbellino, M., Popescu-Dutruit, S.., & Torretta, S. (2020). Acute parotitis: a possible precocious clinical manifestation of SARS-CoV-2 infection? Otolaryngology Head Neck Surg., 163, 182–3. https://doi.org/10.1177%2F0194599820926992.
Center for Disease Control. (2020). Coronavirus. http://www.bccdc.ca/about/news-stories/stories/2020/information-on-novel-coronavirus.
Chen, L. H. (2018). Oral lesions in a patient with confirmed Zika virus infection. Journal of Travel Medicine, 25 (1), 1-5.
Chern, A., Famuyide, A., O., Moonis, G., & Lalwani, A., K. (2020). Sialadenitis: a possible early manifestation of COVID-19. Laryngoscope, 130, 2595–7. https://doi.org/10.1002/lary.29083.
Coll, Y., & Elmahgoub, F. (2021). Could dentists be the first to diagnose COVID-19 due to oral manifestations? Evidence Based Dentistry, 22(2), 49.
Dos Santos et al. (2020). Oral mucosal lesions in a COVID-19 patient: New signs or secondary manifestations? International Journal of Infectious Disease, 97, 326-328.
Dziedzic, A., & Wojtyczka, R. (2020). The impact of coronavirus infectious disease 19 (COVID-19) on oral health. Oral Diseases, 00,1–4.
EghbaliZarch, R., & Hosseinzadeh, P. (2020). COVID-19 from the perspective of dentists: a case report and brief review of more than 170 cases. Dermatol Therapy. 34, e14717. https://doi.org/10.1111/dth.14717.
Farooq. L., & Ali S. (2020). COVID-19 outbreak and its monetary implications for dental practices, hospitals, and healthcare workers. Postgraduate Medicine Journal, 3, 137781. http://dx.doi.org/10.1136/postgradmedj-2020-137781.
Fidan, V., Koyuncu, H., & Akin, O. (2021). Oral lesions in Covid 19 positive patients. American Journal of Otolaryngology., 42,102905. https://doi.org/10.1016/j.amjoto.2021.102905.
Fini, M. B. (2020). Oral saliva and COVID-19. Oral Oncology, 108, 1-4.
Gherlone, E., F., Polizzi, E., Tet, G., De Lorenzo, R., Magnaghi, C., & RovereQuerini, P. (2021). Frequent and persistent salivary gland ectasia and oral disease after COVID-19. Journal of Dental Research, 100, 464–71. https://doi.org/10.1177%2F0022034521997112.
Glavina, A., Biocina-Lukenda, D., Mravak-Stipeti, M., & Markeljevi, J. (2020). Oral symptoms and lesions in SARS-CoV-2-positive patient. Oral Diseases. https://doi.org/10.1111/odi.13596.
Han, P. & Ivanovski, S. (2020). Saliva—Friend and Foe in the COVID-19 Outbreak. Diagnostics, 10, 1-12.
Hocková, B., Riad, A., Valky, J., Šulajová, Z., Stebel, A., & Slávik, R. (2021). Oral complications of ICU patients with COVID-19: case-series and review of two hundred ten cases. Journal of Clinical Medicine, 10, 581. https://doi.org/10.3390/jcm10040581.
Iranmanesh, B., Khalili, M., Amiri, R., Zartab, H. & Aflatoonian, M. (2020). Oral manifestations of COVID-19 disease: A review article Dermatologic Therapy, e14578.
Khabadze, Z., Sobolev, K., Todua, I., & Mordanov, O. (2020). Changes in the oral mucosa and general indicators with COVID 19 (SARS-CoV2): a single-center descriptive study. Endodontics Today., 18, 4–9. https://doi.org/10.1002/rmv.2248.
Leao et al. (2009). Oral Complications of HIV Disease. Clinics (Sao Paulo), 64(5), 459–470.
Lewnard, J. A. (2020). Incidence, clinical outcomes, and transmission dynamics of severe coronavirus disease 2019 in California and Washington: a prospective cohort study. British Medical Journal, 369, 1-9.
Liu, H., Shen, Y., Jing Ning, J., & Qin, J. (2017). Sample Size Calculations for Prevalent Cohort Designs. Stat Methods Medical Research, 26(1), 280–291.
Lzzetti, R. M., Nisi, M., Gabriele, & Graziani, F. (2020). COVID-19 Transmission in Dental Practice: Brief Review of Preventive Measures in Italy. Journal of Dental Research, 99(9) 1030–1038. https://doi.org/10.1177%2F0022034520920580.
Meng L., Hua, F., & Bian, Z. (2020). Coronavirus Disease 2019 (COVID-19): Emerging and Future Challenges for Dental and Oral Medicine. Journal of Dental Research, 12, 22034520914246.
Moulds, J. (2020). How the threat of COVID-19 is affecting people across Africa. https://www.weforum.org/agenda/2020/05/africa-covid-19 coronavirus-pandemic-food-water-perc/.
Patel, J., & Woolley, J. (2021). Necrotizing periodontal disease: oral manifestation of COVID-19. Oral Diseases, 27,768–9. https://doi.org/10.1111/odi.13462.
Pérez-Elías, P., V., M., J. (2020). Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort. Lancet, 20, S2352-3018.
Rekhtman, S., Tannenbaum, R., Strunk, A., Birabaharan, M., Wright, S., Grbic N. et al. (2021). Eruptions and related clinical course among 296 hospitalized adults with confirmed COVID-19. Journal of American Academic of Dermatology, 84, 946– 52. https://doi.org/10.1016/j.jaad.2020.12.046.
Riad, A., Kassem, I., Stanek, J., Badrah, M., Klugarova, J., & Klugar, M. (2021). Aphthous stomatitis in COVID-19 patients: Case-series and literature review. Dermatologic Therapy, 34, e14735. https://doi.org/10.1111/dth.14735.
Rodríguez, D., M., Romera, J., A.. & Villarroel, M. (2020). Oral manifestations associated with COVID-19. Oral Diseases. https://doi.org/10.1111/odi.13555.
Sabino-Silva, R., Jardim, A. C. G., & Siqueira, W. L. (2020). Coronavirus COVID-19 impacts to dentistry and potential salivary diagnosis. Clinical Oral Investigations, 20, 1-12.
Santos, J. A. D., Normando, A. G., Silva, C. R. L. C. D., Acevedo, A. C., Canto, G. D. L. Sugaya, N., Santos-Silva, A. R., & Guerra, E. N. S. (2021). Oral Manifestations in Patients with COVID-19: A Living Systematic Review. Journal of Dental Research, 100 (2), 141-154. https://doi.org/10.1177%2F0022034520957289.
Santosh, A. B., & Muddana, K. (2020). Viral infections of the oral cavity. Journal of Family Medicine and Primary Care, 9 (1), 36-42.
Schoeman, D. & Fielding, B., C. (2019). Coronavirus envelope protein: current knowledge. Virology journal, 16 (69), 1-22.
Shamoo & Resnik, (2003). Responsible Conduct of Research. New York: Oxford university press.
Tapia, C. R. O., Labrador, P. A. J., Guimaraes, D. M., Matos, Valdez, L. H. (2020). Oral mucosal lesions in patients with SARS-CoV-2 infection. Report of four cases. Are they a true sign of COVID-19 disease? Special Care in Dentistry, 40, 555–60. https://doi.org/10.1111/scd.12520.
Tomo, S., Miyahara, G., I., & Simonato, L., E. (2020). Oral mucositis in a SARS-CoV-2- infected patient: Secondary or truly associated condition? Oral Diseases, 86. https://doi.org/10.1111/odi.13570.
Verdoni, L., Mazza, A., Gervasoni, A., Martelli, L., Ruggeri, M., & Ciuffreda, M. (2020). An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet., 395, 1771–8. https://doi.org/10.1016/S0140-6736(20)31103-X.
World Health Organization. (2020). Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). file:///C:/Users/gezah/Downloads/who-china-joint-mission-on-covid-19-final-report.pdf.
World health organization. (2020). What is coronavirus? https://health.howstuffworks.com/diseases-conditions/respiratory/corona-virus.htm.
Xu H., Zhong L., Deng, J., Peng. J., Dan, H. H., & Zeng, X. (2020). High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. International Journal of Oral Science, 12(8).
Ce travail est disponible sous licence Creative Commons Attribution - Pas d’Utilisation Commerciale 4.0 International.